On March 25, 2026, bioAffinity Technologies, Inc. announced that it will host a live virtual physician roundtable featuring pulmonologists discussing the integration of CyPath® Lung into clinical practice. This event aims to provide insights into lung cancer risk assessment, pulmonary nodule management, and the surveillance of lung cancer survivors post-treatment. The roundtable will showcase real-world patient cases where CyPath® Lung has been utilized, highlighting its clinical utility in guiding decision-making for lung cancer diagnosis and management. The webinar is part of a series titled 'CyPath® Lung in Practice' and is scheduled for April 8, 2026. Healthcare providers interested in attending can register through the provided link. This initiative reflects bioAffinity's commitment to advancing noninvasive diagnostic solutions and improving patient outcomes in lung cancer care.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.